KKR & Co. Inc. reports Q1 results on May 21 with options traders at their most defensive in a year — and the stock already down 6.6% on the week to $92.92.
The dominant signal heading into the print is in options. The put/call ratio closed at 2.06 on May 19, just below the 52-week high of 2.18 set the prior session. That reading is nearly 2.9 standard deviations above the 20-day mean of 1.41. This is not a gradual drift — the PCR sat in the 1.27–1.45 range throughout April and the first two weeks of May, then lurched above 2.0 in a single session on Monday. Puts now outnumber calls by roughly two-to-one, the most extreme defensive lean the options market has shown on this name all year. As noted in prior coverage, this spike coincided almost exactly with the earnings date being confirmed for May 21 — the timing is not coincidental.
Short positioning itself remains a supporting character, not the headline. SI % FF edged up to 1.46% — a 4.8% rise on the week — but the absolute level stays low enough that bears are not crowded in. Borrow costs ticked up 13% week-on-week to 0.40%, still historically cheap. Availability remains exceptionally loose, with the lending pool far more than sufficient for current demand. Short sellers face no structural friction. The build in short interest is modest and opportunistic rather than a conviction bear trade.
The Street remains broadly constructive, even as targets have drifted lower. The consensus mean target is $125.69 — implying roughly 35% upside from current levels. Morgan Stanley maintained Overweight but cut its target from $177 to $153 in late April. Barclays and RBC similarly trimmed targets on May 6 while holding positive ratings. TD Cowen nudged its Hold target down a further $2 to $104 this week — the only recent cautious note in an otherwise bullish chorus. UBS bucked the direction entirely, raising its Buy target from $113 to $126 on May 6. The picture is one of a Street that believes in the long-term case but is revising near-term numbers down to reflect macro headwinds. The PE multiple has compressed by about 1.4 turns over 30 days to 14.2x, and the P/B has fallen by 0.30 over the same window to 1.31x — a meaningful re-rating for a firm of KKR's profile.
Bulls point to KKR's diversified fee streams, the growing insurance segment, and what analysts project as a sharp forward EPS recovery — the 12-month forward EPS year-on-year increase factor ranks in the 79th percentile. Bears focus on macro volatility squeezing realization activity, executive stock vesting adding to share count, and sensitivity to credit spreads and capital markets conditions. That tension is the core of the May 21 debate.
Peers sold off hard too, offering some sector-level cover for the week's move. CG dropped 9.0% on the week, TPG fell 8.5%, and BX declined 6.9% — broadly in line with KKR's 6.6% slide. ARES held up better at -2.1%, and BAM was the standout with only a -3.1% move. The sector-wide pressure suggests the KKR drop is a macro and sector re-rating, not a company-specific deterioration — but the elevated PCR relative to peers' options markets indicates KKR specifically is carrying more hedged-in anxiety into its print.
The Q1 release on May 21 is the immediate fulcrum: the question is whether fee-related earnings and AUM flows held up well enough to justify the gap between the current price and analyst targets — or whether management's tone on realization and fundraising reinforces the bears' caution.
See the live data behind this article on ORTEX.
Open KKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
